Measuring HIV-1 incidence in northern Thailand: Prospective cohort results and estimates based on early diagnostic tests

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 5, 1996, Pages 495-499

  Beyrer, Chris ^a,b   Brookmeyer, Ron ^a   Natpratan, Chawalit ^b   Kunawararak, Piyada ^b   Niraroot, Virat ^b   Palapunya, Pongnapit ^b   Khamboonruang, Chirasak ^b   Celentano, David D ^a   Nelson, Kenrad E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b CHIANG MAI UNIVERSITY   (Thailand)

Author keywords

Human immunodeficiency virus; Incidence; p24 Antigen; Thailand

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SEROCONVERSION; SEXUALLY TRANSMITTED DISEASE; THAILAND; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; THAILAND VIRUS;

EID: 0029812372     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608150-00009     Document Type: Article

References (16)

1. Mann J, Tarantola D, Netter T, eds. AIDS in the world. Cambridge: Harvard University Press, 1992.
2. Petricciani J, Koff W, Ada G. Efficacy trials for HIV/AIDS vaccines. AIDS Res Hum Retrovir 1992;8:1527-9.
3. Heyward W, Osmanov S, Saba J, et al. Preparation for Phase III HIV vaccine efficacy trials: methods for the determination of HIV incidence. AIDS 1994;8:1285-91.
4. Brookmeyer R, Quinn T, Shepherd M, Mehendale S, Rodrigues J, Bollinger B. AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates. Am J Epidemiol 1995;142:709-13.
5. Brookmeyer R, Quinn T. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests. Am J Epidemiol 1995; 141:166-72.
6. Weniger B, Limpakarnjanarat K, Thanprasertsuk S, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991;5(suppl 2):s71-85.
7. Royal Thai Ministry of Public Health, Division of Communicable Disease Control HIV/AIDS Surveillance Data, 1989-1993.
8. Kityaporn D, Uneklabh C, Weniger BE, et al. HIV-1 incidence determined retrospectively among drug users in Bangkok, Thailand. AIDS 1994;8:1443-50.
9. Kunawararak P, Beyrer C, Natpratan C, et al. The epidemiology of HIV and syphilis among male commercial sex workers in northern Thailand. AIDS 1995;9:517-21.
10. Nelson KE, Beyrer C, Natpratan C, et al. Preparatory studies for possible HIV vaccine trials in northern Thailand. AIDS Res Hum Retrovir 1994;10(suppl 2):s243-6.
11. Clark S, Campbell-Hill S, Chopra P, et al. Quantitative assessment of viral replication in acute and early chronic HIV-1 infection: implications for natural history and intervention [abstract DOA2132]. Presented at the Eighth International Conference on AIDS/Third Sexually Transmitted Diseases World Congress, Amsterdam, July, 1992;2:A24.
12. Clark S, Kelen GR, Henrard DR, et al. Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J Infect Dis 1994;170: 194-7.
13. Beyrer C, Khamboonruang C, Natpratan C, Celentano DD, Nelson KE. Incident HIV and STDs in direct and indirect commercial sex workers in Thailand. Oral presentation O38C at the International AIDS Conference, Yokohama, August 12-17, 1994.
14. Limpakarnjanarat K, Mastro TD, Korattana S, et al. HIV incidence and AIDS mortality in a cohort of female prostitutes in Chiang Rai, Thailand (Abst B104). Third International Conference on AIDS in Asia and the Pacific, Chiang Mai, Thailand, September 1995.
15. Sawanpanyalert P, Ungchusak K, Thanparsertsuk S, Akarasewi P. Seroconversion rate and risk factors for HIV-1 infection among low class female sex workers in Chiang Mai, Thailand. AIDS 1994;8:825-9.
16. Busch MP, Lee LL, Satten GA, et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35(2):91-7.